$2.30
6.88% today
Nasdaq, Nov 13, 09:17 pm CET
ISIN
US68554V1089
Symbol
OSUR

OraSure Technologies, Inc. Stock price

$2.47
-0.54 17.94% 1M
-0.20 7.49% 6M
-1.14 31.58% YTD
-1.67 40.34% 1Y
-2.71 52.32% 3Y
-10.96 81.61% 5Y
-3.21 56.51% 10Y
-8.67 77.83% 20Y
Nasdaq, Closing price Wed, Nov 12 2025
+0.01 0.41%

Key metrics

Basic
Market capitalization
$177.2m
Enterprise Value
$-39.1m
Net debt
positive
Cash
$216.5m
Shares outstanding
72.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.4 | 1.4
EV/Sales
negative | negative
EV/FCF
0.9
P/B
0.5
Financial Health
Equity Ratio
85.6%
Return on Equity
-4.8%
ROCE
-17.1%
ROIC
-37.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$125.7m | $123.7m
EBITDA
$-62.5m | $-47.9m
EBIT
$-65.3m | $-70.4m
Net Income
$-60.2m | $-64.1m
Free Cash Flow
$-43.7m
Growth (TTM | estimate)
Revenue
-44.0% | -33.4%
EBITDA
-3,774.1% | -280.4%
EBIT
-539.7% | -200.4%
Net Income
-629.8% | -228.9%
Free Cash Flow
-168.2%
Margin (TTM | estimate)
Gross
40.4%
EBITDA
-49.7% | -38.7%
EBIT
-52.0%
Net
-47.9% | -51.8%
Free Cash Flow
-34.7%
More
EPS
$-0.8
FCF per Share
$-0.6
Short interest
5.4%
Employees
501
Rev per Employee
$370.0k
Show more

Is OraSure Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

OraSure Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a OraSure Technologies, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a OraSure Technologies, Inc. forecast:

Buy
75%
Hold
25%

Financial data from OraSure Technologies, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
126 126
44% 44%
100%
- Direct Costs 75 75
42% 42%
60%
51 51
46% 46%
40%
- Selling and Administrative Expenses 76 76
3% 3%
60%
- Research and Development Expense 36 36
34% 34%
29%
-62 -62
3,774% 3,774%
-50%
- Depreciation and Amortization 2.87 2.87
76% 76%
2%
EBIT (Operating Income) EBIT -65 -65
540% 540%
-52%
Net Profit -60 -60
630% 630%
-48%

In millions USD.

Don't miss a Thing! We will send you all news about OraSure Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OraSure Technologies, Inc. Stock News

Neutral
Seeking Alpha
8 days ago
OraSure Technologies, Inc. ( OSUR ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Jason Plagman - Vice President of Investor Relations Carrie Eglinton Manner - President, CEO & Director Kenneth McGrath - Chief Financial Officer Conference Call Participants Steven Etoch - Stephens Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing...
Neutral
GlobeNewsWire
15 days ago
BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025.
Neutral
GlobeNewsWire
16 days ago
Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective  OraSure Board Has Added Three New Independent Directors in the Past Three Years Mara Aspinall to Step Down from the Board; Jack Kenny Appointed as Chair of the Board BETHLEHEM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc....
More OraSure Technologies, Inc. News

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Head office United States
CEO Carrie Manner
Employees 501
Founded 2000
Website www.orasure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today